The Annual East of England Educational Meeting of the Regional Acute Oncology Network took place on Friday, 08 March 2024 with a focus on immunotherapy toxicities. 
The meeting was Chaired by Dr Saif Ahmad, East of England Clinical Lead for AOS. 
The agenda was designed to support clinicians and nurses to recognise and respond to some of the more complex immunotherapy toxicities that are increasingly being seen with more novel and complex treatments. 
Uptake for the event was phenomenal with no spare seats left in the room.
We would like to thank everyone that attended and hope you all found the event helpful.
 
We would particularly like to thank all of our wonderful speakers on the day:
  • Dr Brent O'Carrigan, Consultant Oncologist and Clinical Lead for GLH, CUH
  • Emily Keen, Macmillan Lead Nurse for IO, The Royal Free Hospital
  • Dr Dan Patterson, Medical Oncologist, West Suffolk Foundation Trust
During the afternoon, we had six presentations from Consultants with a Special Interest in the Management of Complex IO Toxicities, Cambridge University Hospital:
  • Gastroenterology: Dr Sree Subramanian, Consultant Gastroenterologist
  • Cardiology: Dr Mun Cheang, Cardio-Oncology Consultant
  • Ophthalmology: Dr Erika Marie Damato, Consultant Medical Ophthalmologist
  • Hepatology: Dr Brent O'Carrigan, Consultant Medical Oncologist
  • Pulmonology: Dr Jurgen Herre, Consultant Physician and Lead Interventional Pulmonologist.
  • Rheumatology: Dr Anshuman Malaviya, Consultant Rheumatologist
 
The day ended with an Expert Panel Discussion to talk about:
  • The complexities of Immunotherapy
  • Improving outcomes in the East of England
  • Potential for development of a Regional Immunotherapy Expert MDT
Presentation slides and recordings are available in the sections below. 

 

AOS Away Day March 2024.jpg

 

Presentation by Dr Brent O'Carrigan, Consultant Medical Oncologist, Addenbrooke's Hospital, Cambridge, CUH Lead, IO Toxicity and Clinical Lead for East GLH.

Dr O'Carrigan talks about 'Immunotherapy: the Mechanisms of Action and When it can be a Troublemaker'. The recording is from the East of England Acute Oncology Educational Day held on Friday, 08 March 2024.

Please use links below to view the presentation slides and recording. 

Presentation by Emily Keen, Macmillan Lead Nurse for Immunotherapy, Royal Free London NHS Foundation Trust at the East of England Acute Oncology Educational Day held on Friday, 08 March 2024. Emily talks about 'Nurse-Led Immunotherapy: The Pros and Cons'.

Please use the links below to access the presentation slides and recording from the day. 

Presentation at the East of England Acute Oncology - Immunotherapy Focus Education Day held on Friday, 08 March 2024 delivered by Dr Dan Patterson, Consultant Medical Oncologist, West Suffolk Foundation Trust. Dr Patterson talks about the West Suffolk Hospital Immunotherapy MDT Journey.
Please use the links below to access the presentation slides and recording from the day. 

  1. Dr Sree Subramanian, Consultant Gastroenterologist, Addenbrooke's Hospital presented on 'Checkpoint inhibor induced colitis'. Please use this link to access the presentation slides.

  2. Dr Mun Cheang, Cardio-Oncology Consultant, Addenbrooke's Hospital presented on 'Immune Checkpoint Inhibitor Myocarditis. Please use this link to access the presentation slides.

  3. Dr Brent O'Carrigan, Consultant Medical Oncologist, Addenbrooke's Hospital, presented on 'Immunotherapy toxicity: Hepatitis'. Please use this link to access the presentation slides.

  4. Dr Erika Marie Damato, Consultant Medical Ophthalmologist, Addenbrooke's Hospital, presented on 'Ocular inflammation in patients treated with immunotherapy'. Please use this link to access the presentation slides.

  5. Dr Jurgen Herre, Consultant Physician and Lead Interventional Pulmonologist, Addenbrooke's Hospital, presented on 'Immunotoxicity Related Pneumonitis'. Please use this link to access the presentation slides.

  6. Dr Anshuman Malaviya, Consultant Rheumatologist, Addenbrooke's Hospital, presented on 'Immune checkpoint inhibitors associated arthritis'. Please use this link to access the presentation slides.